Healthbeat - Your Source for Daily Health Trends and Medical News

A ‘back to work’ approach to mental illness is no panacea | Letters

Readers respond to the health secretary’s announcement that too many people are being ‘written off’ with a diagnosisSuccessive governments refuse to acknowledge that mental illness overwhelming

Recently Issued Guidance Documents

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

Kilmer McCully, Pathologist Scorned for New Theory of Heart Disease, Dies at 91

His studies showed that a B vitamin deficiency could cause hardened arteries. It took the medical profession more than a decade to catch up.

Antimicrobial Resistance

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem.

Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

(MedPage Today) -- Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam Pharmaceuticals announced expanded

Martin Rowson on Labour beating ploughshares into swords – cartoon

'Leaning In' to a Fresh Start in Residency

(MedPage Today) -- Welcome to MedPage Today's "White Coat Chronicles," a short-form feature series where we follow Emilie "Mia" Mathura, DO, MSPH, during her first year of residency in ob/gyn.

Alnylam enters the ATTR-CM drug race

Today in "The Readout" newsletter: Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

Newer Biologics Tied to Fewer Infections for Older Patients With Psoriatic Disease

(MedPage Today) -- Biologics targeting interleukin (IL)-12, IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a Canadian cohort study

Prescription Drug User Fee Amendments

The Prescription Drug User Fee Act (PDUFA) was created by Congress in 1992 and authorizes FDA to collect fees from companies that produce certain human drug and biological products.

All News